發送短信 : A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)

  ______     ___      ____       ___      ______  
 /_____//   / _ \\   |  _ \\    / _ \\   /_   _// 
 `____ `   | / \ ||  | |_| ||  | / \ ||    | ||   
 /___//    | \_/ ||  | .  //   | \_/ ||   _| ||   
 `__ `      \___//   |_|\_\\    \___//   /__//    
 /_//       `---`    `-` --`    `---`    `--`     
 `-`